CN1097739A - 氨基-取代硫醚的制备方法 - Google Patents

氨基-取代硫醚的制备方法 Download PDF

Info

Publication number
CN1097739A
CN1097739A CN94108118A CN94108118A CN1097739A CN 1097739 A CN1097739 A CN 1097739A CN 94108118 A CN94108118 A CN 94108118A CN 94108118 A CN94108118 A CN 94108118A CN 1097739 A CN1097739 A CN 1097739A
Authority
CN
China
Prior art keywords
phenyl
compound
methyl
formula
oxazolidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN94108118A
Other languages
English (en)
Other versions
CN1038127C (zh
Inventor
K·孔德
K·J·赫德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dystar Textilfarben GmbH and Co Deutschland KG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934322053 external-priority patent/DE4322053A1/de
Priority claimed from DE19934332978 external-priority patent/DE4332978A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1097739A publication Critical patent/CN1097739A/zh
Application granted granted Critical
Publication of CN1038127C publication Critical patent/CN1038127C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/29Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

通过2-巯基乙醇与通式(II)的化合物反应制备 式(I)化合物, 取代基同说明书中的定义。

Description

本发明涉及氨基-取代硫醚的新的制备方法。这类化合物及其制备是基本上已知的,见Journal of Medicinal Chemistry,1977,Vol.20,Soloway,Chemo-Immuno-Therapy of Cancer,pp.1357 ff.在J.Org,Chem.1992,57,Poindexter,pp.6257-6265中该文献公开了2-噁唑烷酮对芳香族化合物的氨基乙基化作用。
本发明涉及通式(Ⅰ)化合物的制备方法,
Figure 941081184_IMG4
其中
R,R1-R6各自独立地表示氢,C1-C4-烷基,由羟基C1-C4-烷氧基或SO3H取代的C1-C4-烷基,苯基,苄基,或由卤素、C1-C4-烷氧基或SO3H取代的苯基或苄基;且
n代表0或1;
该方法的特征在于将2-巯基乙醇与通式(Ⅱ)化合物反应,
Figure 941081184_IMG5
其中
R,R1-R6和n为以上给出的定义。
本反应优选在50℃-250℃,更优选在60℃-200℃的温度下进行。
本反应可选择地在溶剂中进行。
可使用的溶剂是那些pKa值明显比2-巯基乙醇低,且其本身不与2-巯基乙醇反应的所有溶剂,例如烃类、醚类、醇类、羧酰胺类、亚砜类和砜类;胺类除外。
尽管2-噁唑烷酮与苯硫酚的反应是已知的,但至今还没有与烷硫醇成功的反应,以生成2-(烷硫基)乙胺化合物(见G.S.Poindexter et al.,J.Org.Chem.1992,57,6257-6265)。
一些式(Ⅱ)化合物是已知的,可采用Houben-Weyl,Vol.E4(1983),192-211页中所述的方法制备这些化合物。
式(Ⅱ)化合物的适当的实例为:
n=2时:
1-氧代-1,3-噁唑烷(2-噁唑烷酮),
5-甲基-2-氧代-1,3-噁唑烷,
3-甲基-2-氧代-1,3-噁唑烷,
3-苯基-2-氧代-1,3-噁唑烷,
3-苄基-2-氧代-1,3-噁唑烷,
4-苯基-2-氧代-1,3-噁唑烷,
5-苯基-2-氧代-1,3-噁唑烷,
3,4-二苯基-2-氧代-1,3-噁唑烷,
3,5-二苯基-2-氧代-1,3-噁唑烷,
3,4-二甲基-5-苯基-2-氧代-1,3-噁唑烷,
3-苯基-4-羟甲基-2-氧代-1,3-噁唑烷,
3,5-二甲基-2-氧代-1,3-噁唑烷,
3-乙基-2-氧代-1,3-噁唑烷,
4-乙基-2-氧代-1,3-噁唑烷;
当n=1时:
四氢[1,3]噁嗪-2-酮,
3-甲基-四氢[1,3]噁嗪-2-酮,
3-苯基-四氢[1,3]噁嗪-2-酮,
3-苄基-四氢[1,3]噁嗪-2-酮,
4-甲基-四氢[1,3]噁嗪-2-酮,
6-甲基-四氢[1,3]噁嗪-2-酮。
优选的方法是制备下述式(Ⅰ)化合物的方法:
其中
R代表氢、甲基、乙基、苯基或苄基,且
R1-R6各自独立地表示氢、甲基和苯基,特别是代表氢。
本发明方法更优选实例的特征在于:将式(Ⅱ)化合物与2-巯基乙醇和碱进行反应,最好用与式(Ⅱ)化合物等摩尔量的碱,式(Ⅱ)中R,R1-R6和n具有上述定义。可使用的碱的实例为碱金属或碱土金属碳酸盐、碱金属醇盐或叔胺,优选醇钠和醇钾。
在此碱诱导的不同方法中,优选的温度是50-150℃,特别是60-110℃,且使用的溶剂的实例为N-甲基吡咯烷酮、己内酰胺,N-甲基己内酰胺、环己醇、二甲基亚砜、二甲基砜、环丁砜、甲醇、乙醇、正丙醇、异丙醇、正丁醇、仲丁醇、异丁醇、叔丁醇、水,或所述溶剂的任意混合物。优选甲醇、乙醇、异丙醇和/或水。
这种碱诱导的不同方法特别优选地是用于制备其中n=0的式(Ⅰ)化合物。
制备其中n=0且R和R1-R6为上述给定定义的式(Ⅰ)化合物的更优选的实例,其特征是将2-巯基乙醇与其中n=0且R和R1-R6为上述给定定义的式(Ⅱ)化合物反应。
本发明方法的变异方法优选在100~250℃,特别在150~200℃温度下,可在溶剂中但优选无溶剂存在下进行。对后一方法可使用的适合溶剂的实例为: 、萘、1-甲基萘、2-甲基萘、萘烷、1,2,3,4-四氢化萘、对氯苯、硝基苯、联苯、二苯基醚、1-己醇、1-庚醇、1-辛醇、2-辛醇、乙二醇、二甘醇、二甘醇单甲醚、二甘醇单乙基醚、甘油、N-甲基吡咯烷酮、己内酰胺、N-甲基己内酰胺、环己醇、二甲基亚砜、二甲基砜和环丁砜,特别是N-甲基吡咯烷醇、己内酰胺和环丁砜。
根据本发明制备的2-(2′-氨基烷硫基)-乙醇可用作药物和农药的中间体,特别是染料中间体。
本发明的方法特别优选地使用下述式(Ⅱ)化合物:3-苯基-2-噁唑烷酮、3-甲基-2-噁唑烷酮、2-噁唑烷酮、3-甲基-四氢[1,3]-噁嗪-2-酮或3-苯基-四氢[1,3]噁嗪-2-酮。
实施例1
在160℃,充N2条件下将78.1g2-巯基乙醇和163g3-苯基-2-噁唑烷酮加热5小时,获得几乎定量产率的2-(2′-苯基氨基乙硫基)乙醇,为浅黄色油,1H NMR谱显示出下述信号:(溶剂D6-DMSO)
δ2.58-2.75ppm,6H,m:δ3.22ppm,2H,t;δ4.80ppm,1H,s;δ6.50-6.61ppm,3H,m;δ7.05ppm,2H,d。
实施例2
在160℃,充N2条件下,将156.2g2-巯基乙醇和202g3-甲基-2-噁唑烷酮加热5小时。减压蒸馏2-(2′-甲基氨基乙硫基)乙醇,获得无色油;b.p.124℃-130℃/5-6.5mm。
实施例3
将78.1g2-巯基乙醇和87g2-噁唑烷酮在沸腾的100ml二甘醇单甲醚中加热5小时,减压条件下先蒸馏出溶剂,然后蒸馏2-(2′-氨基乙硫基)乙醇:b.p.117℃-119℃/3mm。
实施例4
将117g3-苯基-四氢[1,3]噁嗪-2-酮与200ml乙醇一起搅拌,加入70g乙醇钠和80g巯基乙醇,回流条件下加热混合物7小时。反应结束后,蒸馏掉乙醇,剩余物与200ml水一起搅拌。分离出浅黄色油,并鉴定为2-(3′-苯基氨基-正丙基硫基)乙醇。
1H NMR(D6-DMSO):δ1.8ppm,2H,m;δ2.6ppm,4H,m;δ3.09ppm,2H,q;δ3.55ppm,2H,q;δ4.8ppm,1H,t;δ5.56ppm,1H,t;δ6.54ppm,3H,m;δ7.09ppm,2H,m。
实施例5
将74g  N-甲基-1,2-乙醇胺,130g碳酸二乙酯和15g乙醇钠,在90℃于50ml乙醇中缓慢加热随后蒸馏掉乙醇,直至残留物的温度达到110℃。将72g巯基乙醇加入到该热熔的混合物中,且混合物在160℃下加热四小时。在140-145℃/20mm蒸馏纯化新得的2-(2′-甲氨基乙硫基)乙醇。
1H NMR(D6-DMSO/D2O):δ2.26ppm,3H,s;δ2.52-2.65,6H,m;δ3.50,2H,t。

Claims (8)

1、制备通式(Ⅰ)化合物的方法,
Figure 941081184_IMG2
其中
R、R1-R6各自独立地表示氢,C1-C4-烷基,由羟基C1-C4-烷氧基或SO3H取代的C1-C4-烷基,苯基,苄基,或由卤素、C1-C4-烷氧基或SO3H取代的苯基或苄基;且
n代表0或1;
该方法的特征在于将2-巯基乙醇与通式(Ⅱ)化合物反应,
Figure 941081184_IMG3
其中
R,R1-R6和n为以上给出的定义。
2、根据权利要求1的方法,其特征在于其中R代表氢、甲基、乙基、苯基或苄基,且
R1-R6各自独立地代表氢,甲基和苯基。
3、根据权利要求1的方法,其特征在于取代基R1-R6代表氢。
4、根据权利要求1的方法,其特征在于用碱进行反应,优选用与式(Ⅱ)化合物等摩尔量的碱。
5、根据权利要求4的方法,其特征在于反应在50-150℃,优选60-100℃下进行。
6、根据权利要求1的方法,其特征在于用n=0的式(Ⅱ)化合物进行反应。
7、根据权利要求6的方法,其特征在于反应在100-250℃,优选150-200℃下进行。
8、根据上述任一的权利要求,其特征在于使用的式(Ⅱ)化合物为3-苯基-2-噁唑烷酮、3-甲基-2-噁唑烷酮、2-噁唑烷酮、3-甲基-四氢[1,3]噁嗪-2-酮或3-苯基-四氢[1,3]噁嗪-2-酮。
CN94108118A 1993-07-02 1994-07-02 氨基-取代硫醚的制备方法 Expired - Fee Related CN1038127C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19934322053 DE4322053A1 (de) 1993-07-02 1993-07-02 Verfahren zur Herstellung von aminosubstituierten Thioethern
DEP4322053.3 1993-07-02
DE19934332978 DE4332978A1 (de) 1993-09-28 1993-09-28 Verfahren zur Herstellung von aminosubstituierten Thioethern
DEP4332978.0 1993-09-28

Publications (2)

Publication Number Publication Date
CN1097739A true CN1097739A (zh) 1995-01-25
CN1038127C CN1038127C (zh) 1998-04-22

Family

ID=25927329

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94108118A Expired - Fee Related CN1038127C (zh) 1993-07-02 1994-07-02 氨基-取代硫醚的制备方法

Country Status (7)

Country Link
US (1) US5410081A (zh)
EP (1) EP0632022B1 (zh)
JP (1) JPH0717946A (zh)
KR (1) KR100286845B1 (zh)
CN (1) CN1038127C (zh)
DE (1) DE59401383D1 (zh)
TW (1) TW280812B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049623C (zh) * 1994-12-06 2000-02-23 叶元龙 聚乙烯类板材的熔接方法及其装置

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0568876B1 (de) * 1992-05-04 1996-08-28 Bayer Ag Reaktivfarbstoffe, deren Herstellung und Verwendung
DE4441147A1 (de) * 1994-11-18 1996-05-23 Hoechst Ag Verfahren zur Herstellung von 3-(N-Aryl-amino)-propyl-2'-sulfatoethyl-sulfonyl-Verbindungen
WO1998004534A1 (fr) 1996-07-31 1998-02-05 Nikken Chemicals Co., Ltd. Derives de 6-phenyltetrahydro-1,3-oxazine-2-one et compositions medicinales a base de ces composes
AR057218A1 (es) * 2005-12-15 2007-11-21 Astra Ab Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato
JP5486928B2 (ja) * 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックウレアおよびカルバメートインヒビター
ES2395081T3 (es) * 2007-07-26 2013-02-08 Vitae Pharmaceuticals, Inc. Síntesis de inhibidores de la 11beta-hidroxiesteroide deshidrogenasa de tipo 1
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) * 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
WO2009102428A2 (en) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
CA2715290A1 (en) * 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538356B2 (ja) * 2008-03-18 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134384A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5301563B2 (ja) 2008-05-01 2013-09-25 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
EP2324018B1 (en) 2008-07-25 2013-09-04 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
KR20120061771A (ko) * 2009-04-30 2012-06-13 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
EA201300522A1 (ru) 2010-11-02 2013-11-29 Бёрингер Ингельхайм Интернациональ Гмбх Фармацевтические комбинации для лечения метаболических нарушений

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950542A (en) * 1967-02-21 1976-04-13 L'oreal Cysteamine derivatives for oral treatment of seborrhea
EP0498765A1 (de) * 1991-02-04 1992-08-12 Ciba-Geigy Ag Verfahren zur Herstellung von Alkyl- und Arylthiocarbonsäuren und deren Estern

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049623C (zh) * 1994-12-06 2000-02-23 叶元龙 聚乙烯类板材的熔接方法及其装置

Also Published As

Publication number Publication date
EP0632022A3 (en) 1995-02-01
EP0632022B1 (de) 1996-12-27
CN1038127C (zh) 1998-04-22
KR100286845B1 (ko) 2001-04-16
KR950003267A (ko) 1995-02-16
JPH0717946A (ja) 1995-01-20
US5410081A (en) 1995-04-25
DE59401383D1 (de) 1997-02-06
EP0632022A2 (de) 1995-01-04
TW280812B (zh) 1996-07-11

Similar Documents

Publication Publication Date Title
CN1038127C (zh) 氨基-取代硫醚的制备方法
CN1054846C (zh) 在制备具有抗糖尿病和抗肥胖症性能的芳香氨基醇衍生物中的中间化合物的用途
EP1542795B1 (fr) Procede catalytique de fabrication de mercaptans a partir de thioethers
WO2004029005A1 (fr) Procede catlytique de fabrication d’alkylmercaptans apr addition d’hydrogene sulfure sur une olefine
AU608797B2 (en) Process for the preparation of mercaptomethylphenols
CN1511135A (zh) 卤化酯制备方法
EP2099739B1 (fr) Procede de synthese d'esters (meth)acryliques catalyse par un titanate de polyol.
US7838642B2 (en) Process for the preparation of sucralose by the deacylation of trichlorosucrose-6-ethyl ester
CA2117150A1 (fr) Procede de fabrication d'esters halogenes d'acides carboxyliques ou dicarboxyliques
CN1665795A (zh) 杂环氟代链烯基砜的制备方法
CN1238327A (zh) 羰基化合物的立体选择性还原
KR100517772B1 (ko) α-아미노케톤의 환원 방법
CN1213997C (zh) 制备-2-(n-苯基氨基)苯甲酸衍生物的方法
CA2243667A1 (fr) Synthese d'acides carboxyalkylthiosucciniques
CN1305990A (zh) 制备巯甲基酚的改进方法
US6187966B1 (en) Process for preparing optically active alcoholic compounds
US7601869B2 (en) Process for the preparation of Florfenicol
JP3837806B2 (ja) ポリフェノール硫化物の製造方法
CN1176071C (zh) 制备2-烷硫基苯甲酸衍生物的方法
BE1020539A3 (fr) Procede de preparation de 3-(methylthio)propanal.
JPH05501883A (ja) アルコール―エステル分離のための保護ヒドロキシ方法
CN1035002C (zh) 制备环戊烯和环戊烷及环己烷的衍生物的方法
EP0360633B1 (fr) Composition d'oléfines polysulfurées, leur préparation et leur utilisation comme additifs pour lubrifiants
WO2006106244A2 (fr) PROCEDE DE PREPARATION DE β-AMINOESTERS OU α-, β-DIAMINOESTERS DERIVES DE LA SERINE
EP0249556A1 (fr) Procédé de préparation d'esters organiques alpha-halogénés de l'acide carbonique

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: STAFFAN WEARING TEXTILE FIBERS CO., LTD. GERMANY

Free format text: FORMER OWNER: BAYER AG

Effective date: 20050930

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20050930

Address after: Frankfurt, Germany

Patentee after: Dystar Textilfarben GmbH & Co Dutschland K G

Address before: The Federal Republic of Germany Leverkusen

Patentee before: Bayer Aktiengesellschaft

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee